Login / Signup

Innovative therapies for invasive fungal infections in preclinical and clinical development.

Yidong YuKrystyna AlbrechtJürgen GrollAndreas Beilhack
Published in: Expert opinion on investigational drugs (2020)
It is imperative to expand the pipeline of antifungals to tackle emerging fungal resistance against conventional antimycotic drugs, toxicity, and drug-drug interactions. This unmet medical need should not be underappreciated.
Keyphrases
  • healthcare
  • oxidative stress
  • cell wall
  • drug induced
  • cell therapy
  • stem cells
  • emergency department
  • adverse drug
  • mesenchymal stem cells
  • electronic health record